Nisha C. Patel
FDA investigator
Appears on 2 documents from 2025 to 2026, mostly at sites in Ohio. Most often cites nonconforming product (21 CFR 820.90(a)).
- 2
- Documents on file
- 2.5
- Observations per 483
- 2025
- First seen
- 2026
- Most recent
What they cite most
From 5 observations- 21 CFR 820.90(a)Nonconforming product2
- 21 CFR 606.160(a)(1)Records1
- 21 CFR 820.100(a)Corrective and preventive action1
- 21 CFR 820.70(e)Production and process controls1
Activity by year
2025: 1, 2026: 1
Where
Ohio 1
Often inspects with
Is Nisha C. Patel coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
2 documents, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2026-01-12 | 483 Biomat USA IncJan 12, 2026 · Mansfield, Ohio | Mansfield, Ohio | 1 | |
| 2025-03-07 | 483 Aeon Biotherapeutics Corp.Mar 7, 2025 | — | 4 |
About this profile
What does Nisha C. Patel inspect?
Nisha C. Patel appears on 2 documents on file covering 2 sites, mostly in Ohio.
What do they cite most often?
21 CFR 820.90(a) (nonconforming product), followed by 21 CFR 606.160(a)(1) and 21 CFR 820.100(a).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Nisha C. Patel is dated Jan 12, 2026.